Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

This image opens in the lightbox

News provided by

GSK Consumer Healthcare

08 Jul, 2021, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. 

NYON, Switzerland, July 8, 2021 /PRNewswire/ -- Today sees the launch of Let's treat it right, a major new health education campaign designed to bridge a knowledge gap and unlock health benefits for millions of people2. The campaign aims to support the responsible use of everyday medicines such as dosing advice for individuals or family members including children and the elderly, as part of self-care and family care regimes.

Continue Reading
This image opens in the lightbox
Let’s treat it right homepage

Information and resources for both the public and for pharmacists and doctors to help support their conversations on the topic can be found on the new campaign website – www.letstreatitright.com.

With more people now treating themselves at home, increasing numbers have questions and concerns when it comes to using over the counter medicines the right way. The issue was highlighted by a recent study supported by GSK2 which revealed that 80% of Europeans accept that it is their responsibility to manage their own health and are willing to do so,3 yet only two in ten feel confident to actually do this.3  Supporting this, in the past two years, searches for 'self-care' and 'treat at home' have risen by 33% and 58% respectively1, highlighting the need for improved patient resources regarding health self-management.

One area of health that is particularly in focus is the management of pain. According to The Global Pain Index, over three quarters (77%) of people asked wished they could control their pain better.4 Back pain and shoulder pain are also among the top three most common causes of virtual doctor visits.5   But, confusion about the responsible use of medicines extends beyond pain to all areas of everyday health and improved public understanding could reduce the burden on health systems, for example in helping to manage the number of doctor visits.2 As a direct result of the pandemic, positive change is already being seen in this area of self-care with almost half of Europeans (41%) planning to consult their pharmacists more often6, rather than wait for a doctor's appointment. 

At launch, Let's treat it right is focussed on the responsible use of pain medicines with the vision to extend to other areas of everyday health over the next year. Pain is one of the most common medical areas in which people seek information about ways to self-manage with medication. The campaign, supported by the makers of trusted healthcare brands Panadol and Voltaren, aims to provide clear and practical advice to the public about the right use of pain medicines, including individual needs, how much is right to take, and how to dispose of and store their pain medication safely and correctly.

The campaign contains information on four key topics – The Right Need, The Right Dose, The Right Storage and The Right Disposal – available on the website and to be shared on social media channels.

As well as supporting the public, Let's treat it right is also intended as a resource for health experts on the frontline, the millions of pharmacists and doctors who prescribe and support responsible medicines' use for patients and customers. 

Dr Sarah Jarvis, GP and Clinical Director of Patient.info says, "As a GP, I get many questions about the right way to use everyday medicines that are available over the counter. You can find a lot of information online, but it is not always easy to know which sources to trust. That is why I welcome the launch of initiatives like Let's Treat it Right. The campaign provides people with trusted information and advice, for example answering the concerns of parents who have questions about medicine dosage for their children, and elderly patients who are taking medicines for other health conditions. This will allow people to better manage their pain themselves and do so in a responsible manner. I believe that this approach to pain management will help to relieve pressure on healthcare systems and have a positive impact on society globally."

Lars-Åke Söderlund, Executive Committee Member, the International Pharmaceutical Federation (FIP), commented: "The COVID-19 pandemic has led to more people taking responsibility for managing their own health and seeking information in order to do so. Pharmacists, as trusted healthcare professionals who are most accessible to the public, are the first (and often preferred) source of reliable, evidence-based advice and care. Seeking support from pharmacists on over-the-counter pain management is highly beneficial and recommended."

Theresa Agnew, Global Head of Pain Relief Category at GSK Consumer Healthcare said: "Accelerated by the global pandemic, we find ourselves in charge of our health and wellbeing like never before. We want to empower and support consumers when it comes to the responsible use of medicines and support the millions of pharmacists and doctors in their crucial role in this. We need to bridge the knowledge gap and rolling out the Let's treat it right campaign is an important step towards achieving that."

Notes to editors

The campaign is funded by GSK Consumer Healthcare, the maker of trusted brands Panadol and Voltaren. Anyone using our products should always use medicines as directed in the product label. If in any doubt, a doctor or pharmacist should be consulted for advice.

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com/about-us 

1 Google Trends Data. June 2021. Last accessed June 2021. https://trends.google.co.uk/trends/explore?date=2019-06-01%202021-06-10&q=self%20care,Treat%20at%20home
2 The Health-Economic Benefits of Self-care in Europe. Published by Vintura. Supported by GSK. https://assets.gskstatic.com/corporate/Health-Economic-Study/GSK_report_summary-FINAL.pdf. Last accessed June 2021.
3 The EPOSSI Barometer: Consumer Perceptions of self-care in Europe. EPPOSI, 2013. Available at: https://epposi.org/wp-content/uploads/2015/07/EPPOSI-Self-Care-Barometer-Report-2013-EN.pdf. Last accessed June 2021.
4 GSK Global Pain Index (GPI) 4 Report, March 2020. Last accessed June 2021. Promotion PM-GL-VOLT-20-00166. 
5 What Covid-19 Taught Us About Telemedicine; The pandemic gave doctors a crash course in what does and doesn't work. Among the lessons: a good webside manner is crucial. The Wall Street Journal, 28 March 2021. Last accessed June 2021.
6 COVID-19 prompts increased focus on self-care. GSK Consumer Healthcare and IPSOS. July 2020. Last accessed June 2021: COVID-19 prompts increased focus on self-care | GSK

Photo - https://mma.prnewswire.com/media/1559452/LTIR_Homepage.jpg
Logo - https://mma.prnewswire.com/media/1559451/LTIR_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.